The ECJ has followed the opinion of the Advocate General in deciding that the court's decision in Brüstle did not exclude from patentability under the Biotechnology Directive parthenotes, derived from a human ovum by parthenogenesis, which are incapable of developing into a human being. (International Stem Cell Corporation v Comptroller General of Patents, Case C-364/13, 18 December 2014.)